EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring the druggability of the UEV domain of human TSG101 in search for broad‐spectrum antivirals

Fernando Montero, Marisa Parra-López, Alejandro Rodríguez-Martínez, Javier Murciano-Calles, Pedro Buzon, Ziying Han, L-Y Lin, Maria C Ramos, Javier Ruiz-Sanz, Jose C Martinez, Marco Radi, Christiane Moog und 6 weitere

Protein Science · 2025

DOI: 10.1002/pro.70005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, 2025. Verfasst von Fernando Montero und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Chemistry, Institute of Biotechnology, and Unit of Excellence in Chemistry Applied to Biomedicine and Environment, School of S…. Hauptthemen laut MEDLINE: Endosomal Sorting Complexes Required for Transport, Antiviral Agents, DNA-Binding Proteins, Transcription Factors. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Supercomputing infrastructure of the NLHPC (ECM-02, Powered@NLHPC), Extremadura Research Centre for Advanced Technologies (CETA-CIEMAT), funded by the European Regional Development Fund (ERDF), Plataforma Andaluza de Bioinformática of the University of Málaga.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ubiquitin E2 variant domain of TSG101 (TSG101‐UEV) plays a pivotal role in protein sorting and virus budding by recognizing PTAP motifs within ubiquitinated proteins. Disruption of TSG101‐UEV/PTAP interactions has emerged as a promising strategy for the development of host‐oriented broad‐spectrum antivirals with low susceptibility to resistance. TSG101 is a challenging target characterized by an extended and flat binding interface, low affinity for PTAP ligands, and complex binding energetics. Here, we assess the druggability of the TSG101‐UEV/PTAP binding interface by searching for drug‐like inhibitors and evaluating their ability to block PTAP recognition, impair budding, and inhibit viral proliferation. A discovery workflow was established by combining in vitro miniaturized HTS assays and a set of cell‐based activity assays including high‐content bimolecular complementation, virus‐like particle release measurement, and antiviral testing in live virus infection. This approach has allowed us to identify a set of chemically diverse molecules that block TSG101‐UEV/PTAP binding with IC50s in the low μM range and are able to disrupt the interaction between full‐length TSG101 and viral proteins in human cells and inhibit viral replication. State‐of‐the‐art molecular docking studies reveal that the active compounds exploit binding hotspots at the PTAP binding site, unlocking the full binding potential of the TSG101‐UEV binding pockets. These inhibitors represent promising hits for the development of novel broad‐spectrum antivirals through targeted optimization and are also valuable tools for investigating the involvement of ESCRT in the proliferation of different virus families and study the secondary effects induced by the disruption of ESCRT/virus interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endosomal Sorting Complexes Required for TransportAntiviral AgentsDNA-Binding ProteinsTranscription FactorsHumansProtein DomainsBinding SitesMolecular Docking SimulationProtein BindingTsg101 Protein

Stichwörter der Autor:innen

AlphaScreenESCRTTSG101UEV domainbimolecular complementationbroad‐spectrum antiviralscell‐based antiviral assaysdifferential scanning fluorimetrydockinghigh throughput screeningmolecular dynamicsviral late domainsvirus budding

Substanzen

Endosomal Sorting Complexes Required for TransportAntiviral AgentsDNA-Binding ProteinsTranscription FactorsTsg101 Protein

Autor:innen und Institutionen

  • Department of Physical Chemistry, Institute of Biotechnology, and Unit of Excellence in Chemistry Applied to Biomedicine and Environment, School of Sciences, University of Granada, Granada, Spain.
  • Structural Bioinformatics and High-Performance Computing (BIO-HPC) Research Group, Universidad Católica de Murcia (UCAM), Guadalupe, Spain.
  • Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Laboratoire d'ImmunoRhumatologie Moléculaire, UMR_S 1109, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.
  • MEDINA Foundation, Granada, Spain.
  • Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parma, Italy.

ORCID-Profile: Irene Luque

Förderung

  • Supercomputing infrastructure of the NLHPC (ECM-02, Powered@NLHPC)
  • Extremadura Research Centre for Advanced Technologies (CETA-CIEMAT), funded by the European Regional Development Fund (ERDF)
  • Plataforma Andaluza de Bioinformática of the University of Málaga
  • MCIN/AEI/10.13039/501100011033/ and FEDER Una manera de hacer Europa
  • FEDER/Junta de Andalucía-Consejería de Economía y Conocimiento
  • Consejería de Universidad, Investigación e Innovación and FEDER Andalusia Program 2021-2027

Zitieren

APA

Montero, F., Parra-López, M., Rodríguez-Martínez, A., Murciano-Calles, J., Buzon, P., Han, Z., Lin, L. Y., Ramos, M. C., Ruiz-Sanz, J., Martinez, J. C., Radi, M., Moog, C., Diederich, S., Harty, R. N., Pérez-Sánchez, H., Vicente, F., Castillo, F., & Luque, I. (2025). Exploring the druggability of the UEV domain of human TSG101 in search for broad‐spectrum antivirals. Protein Science. https://doi.org/10.1002/pro.70005

Vancouver

Montero F, Parra-López M, Rodríguez-Martínez A, Murciano-Calles J, Buzon P, Han Z, et al. Exploring the druggability of the UEV domain of human TSG101 in search for broad‐spectrum antivirals. Protein Science. 2025. doi:10.1002/pro.70005

BibTeX
@article{Montero2025,
  author = {Montero, Fernando and Parra-López, Marisa and Rodríguez-Martínez, Alejandro and Murciano-Calles, Javier and Buzon, Pedro and Han, Ziying and Lin, L-Y and Ramos, Maria C and Ruiz-Sanz, Javier and Martinez, Jose C and Radi, Marco and Moog, Christiane and Diederich, Sandra and Harty, Ronald N and Pérez-Sánchez, Horacio and Vicente, Francisca and Castillo, Francisco and Luque, Irene},
  title = {Exploring the druggability of the UEV domain of human TSG101 in search for broad‐spectrum antivirals},
  journal = {Protein Science},
  year = {2025},
  doi = {10.1002/pro.70005}
}
Kostenlos starten →